Home Amgen vaccine triggers immune response in advanced melanoma -study
 

Keywords :   


Amgen vaccine triggers immune response in advanced melanoma -study

2014-03-15 09:04:30| Biotech - Topix.net

An experimental Amgen Inc cancer vaccine used to treat advanced melanoma, the deadliest form of skin cancer, proved effective in a late-stage study in shrinking tumors in a way that suggests the drug triggered the intended systemic immune response, according to data presented on Friday.

Tags: advanced study response immune

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.06Atlantic Tropical Weather Outlook
01.06Eastern North Pacific Tropical Weather Outlook
01.06You May Ask Yourself How Did We Get Here?
01.06Retinol Benefits With a Natural and Safe Alternative
01.06Tween Color Cosmetics Brand Talomi Puts a New Face on Beauty 
01.06How HCPA Racks Up Wins At State & Federal Levels
01.06Packaging Can Be Sustainable& Beautiful
01.06This Week in Agribusiness, June 1, 2024
More »